SCHEMBL3880663

SCHEMBL3880663

Cc1ccc(-c2cc(N3CCN(c4ncccc4Cl)C[C@H]3C)nc(N3CCCC3C)n2)cc1F

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 12/20 0.49
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DGAT1 O75907 1/20 0.36
MAP3K12 Q12852 3/20 0.36
MALT1 Q9UDY8 1/20 0.36
HSD11B1 P28845 1/20 0.36
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880768 1.00 TRPV1 (0.49) TRPV1KDM4ENPC1TSHRRAB9A
SCHEMBL3883796 1.00 TRPV1 (0.49) TRPV1KDM4ENPC1TSHRRAB9A
SCHEMBL3941468 0.94 TRPV1 (0.51) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL3878083 0.93 TRPV1 (0.49) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL3879735 0.93 TRPV1 (0.49) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL13761545 0.93 TRPV1 (0.49) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL13761558 0.93 TRPV1 (0.49) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL3888352 0.93 TRPV1 (0.49) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL3883269 0.93 TRPV1 (0.49) TRPV1MAP3K12MALT1HSD11B1CHRM4
SCHEMBL3885655 0.93 TRPV1 (0.46) TRPV1MAP3K12HSD11B1CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed